Trends in patent filings depict a decade of research into the genome-based technologies

Authors

  • Rachel Mercer Marks & Clerk LLP
  • Gareth Williams

DOI:

https://doi.org/10.5912/jcb681

Keywords:

patent, personalized medicine, synthetic biology, sequencing

Abstract

In this article, we look at how patent filings in three key areas of genome-related research indicate the direction of private and public research in sequencing technology, personalised medicine and synthetic biology. Patent landscaping allows for analysis of top filers of patents in these areas and of the patenting behaviour. Each area demonstrates different characteristics, typical of technologies at different stages of development and commercialisation.

Author Biographies

Rachel Mercer, Marks & Clerk LLP

Rachel specialises in patent matters relating to biotechnology and molecular biology.

Gareth Williams

Gareth specialises in biotechnology-related patent work, with particular expertise in genomics and peptides.

Published

2014-09-27

Issue

Section

Legal and Regulatory Updates